Oxford BioMedica (OXB) Stock Statistics & Valuation Metrics

Oxford BioMedica has a market cap or net worth of £615.98M. The enterprise value is 838.44 p.

Oxford BioMedica has 121,049,780 shares outstanding. The number of shares has decreased by -2.65% in one year.

Oxford BioMedica’s return on equity (ROE) is -0.33 and return on invested capital (ROIC) is -11.48%.

The current PE Ratio of Oxford BioMedica is ―. Oxford BioMedica’s PEG ratio is 0.64.

In the last 12 months, Oxford BioMedica had revenue of 168.74M and earned -30.13M in profits. Earnings per share was -0.27.

In the last 12 months, operating cash flow was -26.15M and capital expenditures -10.15M, giving a free cash flow of -36.30M billion.

Oxford BioMedica pays an annual dividend of ―, resulting in a dividend yield of ―

Oxford BioMedica upcoming earnings date is Apr 15, 2027, TBA (Confirmed).

Oxford BioMedica as a current ratio of 2.20, with Debt / Equity ratio of 273.08%

In the past 12 months, Oxford BioMedica has paid -1.29M in taxes.

Oxford BioMedica EV to EBITDA ratio is -81.33, with an EV/FCF ratio of -72.63.

Oxford BioMedica has £75.28M in cash and marketable securities with £158.64M in debt, giving a net cash position of -£83.36M billion.

Gross margin is 36.03%, with operating margin of -17.55%, and net profit margin of -17.85%.

The average price target for Oxford BioMedica is £747.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy